Related Experiment Videos
Analysis of HLA-E expression in human tumors
Rosario Marín1, Francisco Ruiz-Cabello, Susana Pedrinaci
1Departmento de Análisis Clínicos, Hospital Universitario Virgen de las Nieves, Universidad de Granada, Avda. fuerzas Armadas no.2, Spain.
Immunogenetics
|March 6, 2003
Summary
Tumor cells downregulate MHC class Ia to evade T-cells, but can escape NK cells via aberrant HLA-E expression. This occurs in tumors with low MHC class Ia, free beta(2)-microglobulin, and specific HLA-E genotypes.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Tumor cells frequently downregulate MHC class Ia molecules to evade T-cell immunity.
- The mechanisms by which tumors escape Natural Killer (NK) cell-mediated lysis, despite MHC class Ia downregulation, remain incompletely understood.
- Aberrant expression of nonclassical HLA class Ia molecules is hypothesized to provide inhibitory signals to NK cells, promoting tumor escape.
Purpose of the Study:
- To investigate the role of HLA-E expression as a potential NK cell escape mechanism in tumor cells with altered MHC class Ia expression.
- To analyze the correlation between HLA-E cell surface expression and specific genetic and molecular characteristics of tumor cell lines.
Main Methods:
- Utilized monoclonal antibody 3D12 to detect cell surface HLA-E expression on various tumor cell lines with known HLA class Ia alterations.
- Assessed the availability of free beta(2)-microglobulin (beta(2)m) and heavy chain/beta(2)m expression balance.
- Examined tumor cell lines with specific HLA class Ia downregulation, single HLA-A allele expression, and beta(2)m mutations.
Main Results:
- HLA-E was detected in several tumor cell lines, notably leukemia-derived lines, and correlated with the availability of free beta(2)m.
- Tumor cell lines with imbalanced heavy chain/beta(2)m expression, particularly those with heavy chain gene alterations, showed HLA-E expression.
- Reduced HLA class Ia expression paralleled increased HLA-E detection in melanoma systems; specific cervical and melanoma lines with single HLA-A alleles also expressed HLA-E.
- Addition of beta(2)m increased HLA-E surface expression in cells with the HLA-E(G) allele; no HLA-E expression was observed in lines with complete HLA class Ia loss or beta(2)m mutations.
Conclusions:
- Aberrant HLA-E expression in tumors is linked to specific characteristics: MHC class Ia downregulation, free beta(2)m, and HLA-E(G) genotype.
- This aberrant HLA-E expression may represent a significant NK cell escape mechanism, particularly in tumors with reduced HLA-B and -C alleles and a single HLA-A allele.
- The findings highlight a distinct tumor phenotype enabling escape from both T-cell and NK cell-mediated immunity.